Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Annals of Internal Medicine|December 15, 1994
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trialJ L Chiasson, R G Josse, J A Hunt, et al.Diabetes, Obesity & Metabolism|October 10, 2014
Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trialS A Ross, A E Caballero, S Del Prato, et al.Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1995
One-year acarbose treatment raises fasting serum acetate in diabetic patientsT M Wolever, R Radmard, J L Chiasson, et al.The American Journal of Clinical Nutrition|June 1, 1994
Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitusT M Wolever, P M Nguyen, J L Chiasson, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouseS A Ross, J Y Wong, J J Clifford, et al.British Journal of Pharmacology|July 1, 2008
Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig modelX Yao, D L Anderson, S A Ross, et al.Journal of Medical Genetics|September 3, 2004
Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3N M Solomon, S A Ross, T Morgan, et al.Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.Diabetes, Obesity & Metabolism|July 27, 2012
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countriesK Khunti, S Caputo, T Damci, et al.The Journal of Biological Chemistry|March 30, 2001
Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptorM J Zuscik, D Chalothorn, D Hellard, et al.Pageof 15